Physica Medica: European Journal of Medical Physics
Volume 21 , Pages 7-10 , 2006

Promising techniques for breast cancer detection, diagnosis, and staging using non-ionizing radiation imaging techniques

    M.D., Ph.D.
  • Jinha M. Park
    • , M. D.
  • Debra M. Ikeda

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Debra M. Ikeda, M. D. Stanford Advanced Medicine Center 875 Blake Wilbur Drive, Room 2234, Stanford, California 94305-5826 USA.

References 

  1. Boeies C, Barentsz JO, Mus RD, van der Sluis RF, van Erang LJ, Hendriks JH, et al. MR characterization of suspicious breast lesions with a gadolinium-enhancedTurooFLASH subtraction technique. Radiology. 1994;193(3):777–781
  2. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jersen RA, Evans WP, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1994;187(2):493–501
  3. Berg WA, Gutierrez L, Nessaiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic Accuracy of Mammography, Clinical Examination, US, and MR Imaging in Preoperative Assessment of Breast Cancer. Radiology. 2004;
  4. (ACR) ACoR . In: ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas. Reston, VA: American College of Radiology; 2003;
  5. Ikeda DM, Birdwell RL, Daniel BL. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection. Magn Reson Imaging Clin N Am. 2001;9(2):345–356Ikeda DM, Birdwell RL, Daniel BL. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection. Magn Reson Imaging Clin N Am. 2001;9(2):vii
  6. Qayyum A, Birdwell RL, Daniel BL, Nowels KW, Jeffrey SS, Agoston TA, et al. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol. 2002;178(5):122–132
  7. Yen ED, Slanetz PJ, Edmister WB, Talele A, Monticciolo D, Kopans DB. Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging. Breast J. 2003;9(1):13–18
  8. Nunes LW, Schnall MD, Siegelman ES, et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR. 1997;(169):409–415
  9. Kuhl CK, Schild HH. Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging. 2000;12(6):965–974
  10. Kelcz F, Santyr GE, Cron GO, Mongin SJ. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J Magn Reson Imaging. 1996;6(5):743–752
  11. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology. 1999;211(1):101–110
  12. Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schverin EH, Sickles EA, et al. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Eoentgenol. 2000;175(1):35–43
  13. Morris EA, Liberman L, Dershaw DD, Kaplan JB, LaTrenta LR, Abramson AF, et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol. 2002;178(5):1211–1220
  14. Liberman L, Morris EA, Dershaw DD, Thornton CM, Van Zee KJ, Tan LK. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol. 2003;181(5):1283–1293
  15. Daniel BL, Birdwell RL, Ikeda DM, Jeffrey SS, Black JW, Block WF, et al. Breast lesion localization: a freehand, interactive MR imaging-guided technique. Radiology. 1998;207(2):455–463
  16. Lee CH. Problem solving M R imaging of the breast. Radiol Clin North Am. 2004;42(5):919–934Lee CH. Problem solving M R imaging of the breast. Radiol Clin North Am. 2004;42(5):vii
  17. Ikeda DM, Baker DR, Daniel BL. Magnetic resonance imaging of breast cancer: clinical indications and breast MRI reporting system. J Magn Reson Imaging. 2000;12(6):975–983
  18. Tjalma WA, Verslegers IO. Nipple discharge and the value of M R imaging. Eur J Obstet Gynecol Reprod Biol. 2004;115(2):234–236
  19. Offodile RS, Daniel BL, Jeffrey SS, Wapnir I, Dirbas FM, Ikeda DM. Magnetic resonance imaging of suspicious breast masses seen on one mammographic view. Breast J. 2004;10(5):416–422
  20. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. Jama. 2004;292(11):1317–1325
  21. Liberman L, Morris EA, Kim CM, Kaplan JB, Abramson AF, Menell JH, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol. 2003;180(2):333–341
  22. Boppart SA, Luo W, Marks DL, Singletary KW. Optical coherence tomography: feasibility for basic research and image-guided surgery of breast cancer. Breast Cancer Res Treat. 2004;84(2):85–97
  23. Cerussi AE, Berger AJ, Bevilacqua F, Shah N, Jakubowski D, Butler J, et al. Sources of absorption and scattering contrast for near-infrared optical mammography. Acad Radiol. 2001;8(3):11–18
  24. Shah N, Cerussi AE, Jakubowski D, Hsiang D, Butler J, Tromberg BJ. The role of diffuse optical spectroscopy in the clinical management of breast cancer. Dis Markers. 2003;19(2–3):95–105
  25. Shah N, Cerussi A, Eker C, Espinoza J, Butler J, Fishkin J, et al. Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci USA. 2001;98(8):4420–4425
  26. Pogue BW, Jiang S, Dehghani H, Kogel C, Soho S, Srinivasan S, et al. Characterization of hemoglobin, water, and NIR scattering in breast tissue: analysis of intersubject variability and menstrual cycle changes. J Biomed Opt. 2004;9(3):541–552
  27. Jiang H, Xu Y, Iftimia N, Eggert J, Klove K, Baron L, et al. Three-dimensional optical tomographic imaging of breast in a human subject. IEEE Trans Med Imaging. 2001;20(12):1334–1340
  28. Ntziachristos V, Chance B. Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res. 2001;3(1):41–46
  29. Ntziachristos V, Yodh AG, Schnall MD, Chance B. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia. 2002;4(4):347–354
  30. Andreev VG, Karabutov AA, Oraevsky AA. Detection of ultrawide-band ultrasound pulses in optoacoustic tomography. IEEE Trans Ultrason Ferroelectr Freq Control. 2003;50(10):1383–1390
  31. Ebert B, Sukowski U, Grosenick D, Wabnitz H, Moesta KT, Licha K, et al. Near-infrared fluorescent dyes for enhanced contrast in optical mammography: phantom experiments. J Biomed Opt. 2001;6(2):134–140
  32. Copland JA, Eghtedari M, Popov VL, Kotov N, Mamedova N, Motamedi M, et al. Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography. Mol Imaging Biol. 2004;6(5):341–349
  33. Boehm T, Hochmuth A, Malich A, Reichenbach JR, Fleck M, Kaiser WA. Contrast-enhanced near-infrared laser mammography with a prototype breast scanner: feasibility study with tissue phantoms and preliminary results of imaging experimental tumors. Invest Radiol. 2001;36(10):573–581
  34. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductors quantum dots. Nat Biotechnol. 2003;21(1):41–46
  35. Rice BW, Cable MD, Nelson MB. In vivo imaging of light-emitting probes. J Biomed Opt. 2001;6(4):432–440
  36. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003;17(5):545–580
  37. Hilger I, Leistner Y, Berndt A, Fritsche C, Haas KM, Kosmehl H, et al. Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol. 2004;14(6):1124–1129
  38. Mahmood U, Tung CH, Bogdanov A, Weissleder R. Near-infrared optical imaging of protease activity for tumor detection. Radiology. 1999;213(3):866–870
  39. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med. 2002;8(7):757–760
  40. Bremer C, Ntziachristos V, Weissleder R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol. 2003;13(2):231–243

PII: S1120-1797(06)80014-1

doi: 10.1016/S1120-1797(06)80014-1

Physica Medica: European Journal of Medical Physics
Volume 21 , Pages 7-10 , 2006

Article Tools